You've just added:

Home / News

News + Media

April 26, 2023

Harrington Discovery Institute Announces 2023 Scholar-Innovator Award Recipients

10 physician-scientists have been selected for drug development grant to advance discoveries into the clinic Continue Reading

April 10, 2023

Harrington Discovery Institute Opens Call for 2024 Harrington Scholar-Innovator Award

Unique program for physician-scientists to advance promising discoveries into medicines Continue Reading

March 07, 2023

International Harrington Prize Jointly Awarded to Drs. Jean Bennett and Albert Maguire

2023 Harrington Prize for Innovation in Medicine Recognizes Pioneering Work in Retinal Gene Therapy for Genetic Diseases Continue Reading

March 01, 2023

Cleveland Researchers Reveal How Oxygen is Delivered to Tissues, Open Door to New Class of Drugs

Newfound clarity on the longstanding “medical mystery” may lead to new line of drugs for oxygen delivery disorders, including peripheral artery disease, sickle cell disease, heart failure, and others Continue Reading

February 23, 2023

Discovery of Potential New Way to Prevent Vision Loss

UVA Health School of Medicine scientists have discovered an unknown contributor to harmful blood vessel growth in the eye that could lead to new treatments for blinding macular degeneration and other common causes of vision loss. Continue Reading

February 14, 2023

Broad ALS Targets Show Signs of Success in Treating Genetic and Sporadic Forms

Studies published from researchers at the biotech startup AcuraStem and the University of Southern California validated two potential drug targets in animal models of both genetic and sporadic ALS, paving the way for broad treatments. Continue Reading

February 14, 2023

Thylacine Biotherapeutics Licenses Novel Antiviral Peptide Platform from Columbia University

Thylacine Biotherapeutics Inc. entered into a license agreement with Columbia University for worldwide exclusive rights to develop and commercialize a novel antiviral peptide platform. Continue Reading

February 10, 2023

Potential Therapeutic Target for Blood Cancers Discovered

Investigators discovered that a specific complex drives cell proliferation in different forms of blood cancers called mutated myeloproliferative neoplasms (MPNs), suggesting the complex could serve as an ideal therapeutic target for blood cancer. Continue Reading

February 08, 2023

Single Drug Injection Wards off COVID-19 Hospitalizations, in Stanford Medicine-Led Trial

In an international, multicenter, pivotal Phase 3 trial, a single under-the-skin injection of a biological drug given to patients within seven days of the onset of COVID-19 symptoms cut the likelihood they needed to be hospitalized in half. Continue Reading